Cellular and molecular mechanisms of regulation of autoantibody production in lupus

被引:39
作者
Hahn, BH
Ebling, F
Singh, RR
Singh, RP
Karpouzas, G
La Cava, AA
机构
[1] Univ Calif Los Angeles, Div Rheumatol, David Geffen Sch Med, Los Angeles, CA 90095 USA
[2] Univ Cincinnati, Coll Med, Dept Internal Med, Cincinnati, OH USA
[3] Harbor UCLA Med Ctr, Torrance, CA 90509 USA
来源
AUTOIMMUNE DISEASES AND TREATMENT: ORGAN-SPECIFIC AND SYSTEMIC DISORDERS | 2005年 / 1051卷
关键词
systemic lupus erythematosus; CD8(+) T cells; regulatory T cells; suppressor T cells;
D O I
10.1196/annals.1361.085
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The hyperactive interaction between helper T cells and autoimmune B cells in individuals predisposed to systemic lupus erythematosus (SLE) can be interrupted by induction of regulatory and suppressor T cells. Using two strategies-high dose tolerance to an immunoglobulin-derived peptide, and minigene vaccination with DNA encoding T cell epitopes presented by MHC class I molecules-our group has induced at least three types of regulatory/suppressive T cells. They include CD8(+) T cells that suppress helper T cells by cytokine secretion, CD8+ T suppressors that kill B cells making anti-DNA antibodies, and peptide-binding CD4(+)CD25(+) regulatory T cells that suppress B cells by direct cell contact. Each of these lymphocyte subsets suppresses anti-DNA antibody production and delays the onset of nephritis in BWF1 lupus-prone mice. Patients with SLE have amino acid sequences similar to those from murine anti-DNA antibodies used in these studies, and at similar locations in the VH regions of anti-DNA immunoglobulins. Therefore, strategies described here might ultimately be useful in therapy of the human disease.
引用
收藏
页码:433 / 441
页数:9
相关论文
共 32 条
[1]  
Boden Elisa, 2003, Novartis Found Symp, V252, P55
[2]  
CONNOLLY DJ, 1993, J IMMUNOL, V151, P6089
[3]   Quantification of regulatory T cells in patients with systemic lupus erythematosus [J].
Crispin, JC ;
Martínez, A ;
Alcocer-Varela, J .
JOURNAL OF AUTOIMMUNITY, 2003, 21 (03) :273-276
[4]   Vaccination with minigenes encoding VH-derived major histo compatibility complex class I-binding Epitopes activates cytotoxic T cells that ablate autoantibody-producing B cells and inhibit lupus [J].
Fan, GC ;
Singh, RR .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (06) :731-741
[5]   Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function [J].
Filaci, G ;
Fravega, M ;
Negrini, S ;
Procopio, F ;
Fenoglio, D ;
Rizzi, M ;
Brenci, S ;
Contini, P ;
Olive, D ;
Ghio, M ;
Setti, M ;
Accolla, RS ;
Puppo, F ;
Indiveri, F .
HUMAN IMMUNOLOGY, 2004, 65 (02) :142-156
[6]   Impairment of CD8+ T suppressor cell function in patients with active systemic lupus erythematosus [J].
Filaci, G ;
Bacilieri, S ;
Fravega, M ;
Monetti, M ;
Contini, P ;
Ghio, M ;
Setti, M ;
Puppo, F ;
Indiveri, F .
JOURNAL OF IMMUNOLOGY, 2001, 166 (10) :6452-6457
[7]   Characteristics of T cells that participate in the pathogenesis of SLE [J].
Hahn, B ;
Datta, S .
LUPUS, 1997, 6 (03) :330-332
[8]  
Hahn BH, 2001, ARTHRITIS RHEUM-US, V44, P432, DOI 10.1002/1529-0131(200102)44:2<432::AID-ANR62>3.0.CO
[9]  
2-S
[10]   Control of regulatory T cell development by the transcription factor Foxp3 [J].
Hori, S ;
Nomura, T ;
Sakaguchi, S .
SCIENCE, 2003, 299 (5609) :1057-1061